Skip to content

CancerIndexthe global index of cancer

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Endometrial Neoplasm — Research · CancerIndex

Cancers
Neoplasm
Neoplasm by Site
Genitourinary System Neoplasm
Reproductive System Neoplasm
Female Reproductive System Neoplasm
Uterine Neoplasm
Uterine Corpus Neoplasm
Endometrial Neoplasm

Subtype

Endometrial Neoplasm

CI-CAN-00007648Explore in graph →

Non-malignant400 active trials4 approved drugs28 evidence items

NCIt: C3012
MeSH: D016889

Overview
Statistics
Survival
Genomics19
Variants & evidence28
Drugs14
Trials1340
Research
Rankings
Sources & provenance

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Trials tab
Methodology: publication counts

Literature

Linked publications (28)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedProvenance

Source: PubMed (NLM)
Dataset: PubMed E-utilities
Retrieved: Sep 8, 2026
Layer: normalized (units and labels harmonized; values unchanged)

PublishedShowing 1–25 of 28 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

ATR mutation in endometrioid endometrial cancer is associated with poor clinical outcomes.
· J Clin Oncol · 2009 · PMID 19470935 · validated civic_curation pubmed
Racial differences in the overexpression of epidermal growth factor type II receptor (HER2/neu): a major prognostic indicator in uterine serous papillary cancer.
· Am J Obstet Gynecol · 2005 · PMID 15746676 · validated civic_curation pubmed
Elevated expression of RIT1 correlates with poor prognosis in endometrial cancer.
· Int J Clin Exp Pathol · 2015 · PMID 26617739 · validated civic_curation pubmed
Stathmin protein level, a potential predictive marker for taxane treatment response in endometrial cancer.
· PLoS One · 2014 · PMID 24587245 · validated civic_curation pubmed
Molecular determinants of outcome with mammalian target of rapamycin inhibition in endometrial cancer.
· Cancer · 2014 · PMID 24166148 · validated civic_curation pubmed
Predicting everolimus treatment efficacy in patients with advanced endometrial carcinoma: a GINECO group study.
· Target Oncol · 2013 · PMID 23238879 · validated civic_curation pubmed
Phase I Dose-Escalation Study of JNJ-42756493, an Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients With Advanced Solid Tumors.
· J Clin Oncol · 2015 · PMID 26324363 · validated civic_curation

Showing 1–25 of 28 publications

← Previous
1
2
Next →

KRAS gene amplification and overexpression but not mutation associates with aggressive and metastatic endometrial cancer.

· Br J Cancer · 2012 · PMID 23099803 · validated civic_curation pubmed

Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: a Gynecologic Oncology Group study.

· Gynecol Oncol · 2010 · PMID 19840887 · validated civic_curation pubmed

Trastuzumab treatment in patients with advanced or recurrent endometrial carcinoma overexpressing HER2/neu.

· Int J Gynaecol Obstet · 2008 · PMID 18555254 · validated civic_curation pubmed

Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer.

· J Clin Invest · 2016 · PMID 27159395 · validated civic_curation pubmed

Detection of complete response to imatinib mesylate (Glivec/Gleevec) with 18F-FDG PET/CT for low-grade endometrial stromal sarcoma.

· Cancer Chemother Pharmacol · 2009 · PMID 18607592 · validated civic_curation pubmed

A case of c-kit positive high-grade stromal endometrial sarcoma responding to Imatinib Mesylate.

· Gynecol Oncol · 2006 · PMID 16487996 · validated civic_curation pubmed

Somatic aberrations of mismatch repair genes as a cause of microsatellite-unstable cancers.

· J Pathol · 2014 · PMID 25111426 · validated civic_curation pubmed

Antitumor effects and molecular mechanisms of ponatinib on endometrial cancer cells harboring activating FGFR2 mutations.

· Cancer Biol Ther · 2016 · PMID 26574622 · validated civic_curation pubmed

Inhibition of activated fibroblast growth factor receptor 2 in endometrial cancer cells induces cell death despite PTEN abrogation.

· Cancer Res · 2008 · PMID 18757403 · validated civic_curation pubmed

PI3K pathway dependencies in endometrioid endometrial cancer cell lines.

· Clin Cancer Res · 2013 · PMID 23674493 · validated civic_curation pubmed

Targeting CCNE1 amplified ovarian and endometrial cancers by combined inhibition of PKMYT1 and ATR.

· Nat Commun · 2025 · PMID 40169546 · validated civic_curation pubmed

Effect of MRE11 loss on PARP-inhibitor sensitivity in endometrial cancer in vitro.

· PLoS One · 2014 · PMID 24927325 · validated civic_curation pubmed

Le Gallo et al. Cancer 2017

· 2017 · PMID 28485815 · validated cbioportal_study pubmed

Weigelt et al. Cancer Discovery 2023

· 2023 · PMID 37651310 · validated cbioportal_study pubmed

Ashley et al. Clin Cancer Res 2023

· 2023 · PMID 36007103 · validated cbioportal_study pubmed

· PMID 35849120 · validated cbioportal_study pubmed

Yongchao Dou et al. 2020 Cell.

· 2020 · PMID 32059776 · validated cbioportal_study pubmed

Soumerai et al. Clin Cancer Res. 2018

· 2018 · PMID 30068706 · validated cbioportal_study pubmed